MENU

Clinical Use of the Cannabinoids with Case Reports and Discussion

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Palliative Patient Care Corp
    Biography
      Dr. Kent Crowley has over 30 years experience in the pharmaceutical industry and clinical medicine. He obtained his Doctor of Pharmacy from the University of California, San Francisco; completed an ASHP Accredited Residency with Kaiser Permanente. He is an Advanced Fellow and Diplomat of the American Academy of Anti-Aging Medicine.

      At Silver State Trading, a 40,000 sq.ft. Clean Green cultivation and production facility in Sparks, NV, Dr. Crowley serves as the Director of Research and Development, overseeing the production of Trokie® products and future patents. Dr. Crowley is the founder and creator of Trokie®, a patented buccal delivery system for cannabis (U.S. Patent No.: 9,675,656 B2) and runs the California operations for Trokie California Inc.

      Dr. Crowley serves as the Chief Medical Officer of the Palliative Care Corp, a clinic in Huntington Beach, CA that has treated over 3000 patients incorporating cannabis in disease state treatment and symptoms management, whether as a primary treatment or complementary to traditional and/or other modalities. He has recently published on this effort in Frontiers in Neuroscience, Aug 2018.

      Dr. Crowley is a member of the Society of Cannabis Clinicians and on the Research Subcommittee, a member of the International Cannabinoid Research Society and a member of the Integrative Think Tank for University of California Irvine, Center for the Study of Cannabis.

    Abstract

    The use of medically unsupervised cannabis use is exponentially growing in the USA. Healthcare providers need to not only recognize this fact but embrace it with the goal of avoiding drug-drug interactions and improving therapeutic outcomes. The goal of this activity is to provide pharmacists and pharmacy technicians with real world experience in the use of cannabis in disease state management; discuss clinical case studies and the importance of knowing how formulation, active ingredients and route of administration impacts the onset of action, duration of action and therapeutic outcomes. Published data as well as personal experience treating over 3000 patients with cannabis in a Functional medicine clinic will be shared.

    Learning Objectives: 

    1. List the most common medical indications that cannabis is used for today 

    2. Discuss the importance of knowing why the formulation and route of administration impacts the onset and duration of phytocannabinoid therapy

    3. Discuss the value of cannabis as an alternative or adjunct treatments in chronic pain conditions with or without opiates


    Show Resources
    You May Also Like
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    JAN 21, 2021 8:00 AM PST
    JAN 21, 2021 8:00 AM PST
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 19, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 19, 2021 8:00 AM PDT
    Date: Apri 19, 2021 Time: 8:00am PDT, 5:00pm CEST Since the inception of modern biological research, BioSafety has evolved into a critical consideration in Good Laboratory Practices (GLP). Wi...
    Loading Comments...
    Show Resources
    Attendees
    • See more